EMA Warning For Ariad’s Iclusig, While CHCs Get The Benefit Of The Doubt
This article was originally published in The Pink Sheet Daily
Executive Summary
EMA doesn’t suspend, but warns on Ariad’s leukemia drug Iclusig for potential blood clots, while saying combined hormonal contraceptives’ benefit outweighs their risk.